Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Nebulised hypertonic saline in the treatment of viral bronchiolitis in infants Source: ISSN=ISSN 1810-6838, ISBN=, page=160 Year: 2007
Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
Effects of nebulizer therapy by hypertonic saline, gender and breastfeeding on evolution of acute bronchiolitis Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
The efficacy of hélium-oxygen mixture (65%-35%) in acute asthma exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 540s Year: 2004
Medium dose budesonide/formoterol in fixed combination improves lung function over 2-3 weeks in patients with acute obstructive bronchitis of viral etiology Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach Year: 2010
The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial Source: Eur Respir J 2014; 44: 913-921 Year: 2014
IV salbutamol as alternative treatment to intubation in RSV epidemic acute infantile bronchiolitis Source: Annual Congress 2003 - New perspectives in bronchiolitis Year: 2003
Hypertonic saline for acute viral bronchiolitis: take the evidence with a grain of salt Source: Eur Respir J 2014; 44: 827-830 Year: 2014
Inhalation therapy with hypertonic saline (3%) – A treatment option for airway disease in children? Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
Montelukast attenuates the airway response to hypertonic saline in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Cost-effective management of bronchiolitis in infants: 90% versus 94% oxygen saturation Source: International Congress 2015 – Paediatric pulmonary infections: mechanisms and treatment Year: 2015
Long-term outcome of infants treated for acute bronchiolitis with inhaled steroids Source: Eur Respir J 2001; 18: Suppl. 33, 169s Year: 2001
Albuterol is better than epinephrine for treating bronchiolitis Source: Breathe 2008; 5: 74 Year: 2008